Reata Pharmaceuticals, Inc. stock in dollars price history, chart for July 2020
Reata Pharmaceuticals, Inc. stocks price changed by -6.43% in July 2020. Lowest price of RETA stock in July 2020 was 147.7 US dollar. Highest price of RETA stock in July 2020 was 163.34 US dollar.
Show:
Reata Pharmaceuticals, Inc. (RETA)
to
US dollar (USD)
Reata Pharmaceuticals, Inc. US dollar value history
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
Date
Rate
31/07/2020
147.7 USD
30/07/2020
153.59 USD
29/07/2020
154.2 USD
28/07/2020
152.97 USD
27/07/2020
159.2 USD
24/07/2020
157.36 USD
23/07/2020
156.71 USD
22/07/2020
159.61 USD
21/07/2020
159.27 USD
20/07/2020
163.34 USD
17/07/2020
160.97 USD
16/07/2020
154.64 USD
13/07/2020
153.03 USD
10/07/2020
154.4 USD
07/07/2020
158.66 USD
02/07/2020
157.85 USD
Reata Pharmaceuticals, Inc. stocks data
RETA stock price
Reata Pharmaceuticals, Inc. stock price today, RETA stock quote.
RETA stock price
RETA live price
Reata Pharmaceuticals, Inc. stock price real-time, RETA stock live, RETA live market watch.
RETA live price
Reata Pharmaceuticals, Inc. financials
